Stock listing

ASX:BMT Beamtree Holdings Ltd Share Price

Follow Beamtree Holdings Ltd into a list and get an email when it puts out news.

Share price · ASX:BMT

$0.065 AUD -0.003 (-4.4%)

Close on Nov 20, 2026

Past year -67.5% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.065 – $0.067 AUDNov 20, 2026
Volume
22,555 sharesNov 20, 2026
Market cap
$19.20M AUDAt the close on Nov 20, 2026 · price × 295.3M shares outstanding
52-week range
$0.063 – $0.225 AUDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$10,858 AUDMedian day 70,363 shares · 8 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Beamtree Holdings Ltd logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · ASX:BMT · AUD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.065-0.003-4.4%$0.067$0.067$0.06522,555
$0.068+0.001+1.5%$0.068$0.068$0.06887,832
$0.067-0.001-1.5%$0.068$0.068$0.067126,734
$0.0680.0000.0%$0.068$0.068$0.06830,000
$0.068-0.004-5.6%$0.067$0.073$0.06563,946
$0.0720.0000.0%$0.072$0.072$0.0720
$0.0720.0000.0%$0.071$0.073$0.07162,158
$0.072+0.002+2.9%$0.070$0.072$0.070215,086
$0.0700.0000.0%$0.071$0.071$0.070715,466
$0.070+0.004+6.1%$0.064$0.071$0.064232,139
$0.066+0.002+3.1%$0.065$0.066$0.065326,523
$0.064-0.002-3.0%$0.065$0.065$0.064259,353
$0.066-0.005-7.0%$0.065$0.066$0.063198,226
$0.071-0.001-1.4%$0.071$0.071$0.071149,961
$0.072+0.001+1.4%$0.071$0.076$0.071616,503
$0.071-0.006-7.8%$0.078$0.078$0.070123,592
$0.0770.0000.0%$0.077$0.077$0.077104,638
$0.077+0.002+2.7%$0.077$0.077$0.07772,726
$0.0750.0000.0%$0.075$0.075$0.07511,638
$0.075-0.014-15.7%$0.089$0.089$0.075253,246
$0.089-0.001-1.1%$0.089$0.089$0.0895,000
$0.0900.0000.0%$0.090$0.090$0.0905,000
$0.0900.0000.0%$0.090$0.090$0.0900
$0.0900.0000.0%$0.090$0.090$0.0900
$0.090-0.003-3.2%$0.093$0.093$0.09076,100
$0.093+0.003+3.3%$0.093$0.093$0.0931,075
$0.090-0.001-1.1%$0.090$0.090$0.09068,000
$0.0910.0000.0%$0.091$0.091$0.0918,000
$0.091+0.008+9.6%$0.090$0.091$0.090109,547
$0.0830.0000.0%$0.083$0.083$0.08221,310
$0.083-0.007-7.8%$0.088$0.090$0.083125,109
$0.0900.0000.0%$0.090$0.090$0.0900
$0.090-0.010-10.0%$0.094$0.094$0.09024,976
$0.1000.0000.0%$0.100$0.100$0.1000
$0.1000.0000.0%$0.100$0.100$0.1005,000
$0.1000.0000.0%$0.100$0.100$0.10030,000
$0.100+0.008+8.7%$0.092$0.100$0.09227,445
$0.092-0.005-5.2%$0.095$0.095$0.09256,798
$0.097-0.003-3.0%$0.097$0.097$0.097100,000
$0.1000.0000.0%$0.100$0.100$0.1000
$0.100-0.005-4.8%$0.100$0.100$0.095167,554
$0.105-0.010-8.7%$0.110$0.110$0.100138,435
$0.1150.0000.0%$0.115$0.115$0.1150
$0.1150.0000.0%$0.115$0.115$0.11511,638
$0.115+0.010+9.5%$0.115$0.115$0.1151,026
$0.1050.0000.0%$0.105$0.105$0.100283,939
$0.1050.0000.0%$0.105$0.105$0.100127,917
$0.1050.0000.0%$0.113$0.115$0.105233,282
$0.1050.0000.0%$0.105$0.105$0.10512,324
$0.1050.0000.0%$0.110$0.110$0.105122,732
$0.105-0.005-4.5%$0.110$0.120$0.105146,777
$0.1100.0000.0%$0.110$0.110$0.1100
$0.110-0.005-4.3%$0.115$0.115$0.110318,999
$0.115-0.005-4.2%$0.115$0.115$0.11564,814
$0.120+0.010+9.1%$0.110$0.120$0.110225,217
$0.110-0.005-4.3%$0.110$0.120$0.100809,592
$0.115+0.010+9.5%$0.100$0.115$0.100146,929
$0.105-0.005-4.5%$0.100$0.110$0.100136,898
$0.110-0.010-8.3%$0.120$0.120$0.110220,314
$0.120-0.010-7.7%$0.120$0.120$0.1201,421
$0.130+0.005+4.0%$0.125$0.130$0.12040,478
$0.1250.0000.0%$0.125$0.130$0.12535,479
$0.125+0.005+4.2%$0.110$0.135$0.110132,631
$0.120+0.005+4.3%$0.115$0.120$0.11567,096
$0.115-0.005-4.2%$0.120$0.120$0.10529,869
$0.120+0.012+11.6%$0.110$0.120$0.110142,161
Ticker
ASX:BMT
Asset type
Stock
Sector
Health care
Industry
Health care services
Exchange
ASX
Currency
AUD

What changed lately

Latest news

Annual Report to shareholders

Oct 22, 2026

Closed $0.075 (-15.7%) on Oct 23, 2026

Notice of Annual General Meeting/Proxy Form

Oct 22, 2026

Closed $0.075 (-15.7%) on Oct 23, 2026

Cleansing Notice

Aug 27, 2026

Closed $0.12 (-7.7%) on Aug 28, 2026

FY26 Annual Results Investor Presentation

Aug 27, 2026

Closed $0.12 (-7.7%) on Aug 28, 2026

FY26 Full-Year Investor Update

Aug 27, 2026

Closed $0.12 (-7.7%) on Aug 28, 2026

All Beamtree Holdings Ltd news

Beamtree Holdings Ltd on 6ix

Sector
Health care
Industry
Health care services
News releases
24 in the last 12 months · 107 in all · newest Oct 22, 2026 · oldest 2019
Decks
23 decks · latest Aug 28, 2026

Valuation

EV/sales 0.7× against a median of 1.4×: 5th lowest of 11 Health care services companies shown. Statements: Year to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$20.72M AUD
P/E
Loss
EV/sales
0.7×
EV/EBITDA
149×
Price/book
0.8×
Gross margin
−2.5%
Operating margin
−17.1%
Net margin
−62.6%
Debt to equity
0.2×
Beta
No index for this market yet

Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Beamtree Holdings Ltd · ASX:BMTUS$12.71MUS$13.72Mn/a0.7×149×0.8×−62.6%0.2×n/a
Pacific Health Care Organization, Inc. · OTC:PFHOUS$14.08MUS$11.43M12.9×1.8×n/a1.0×17.1%0.0×-0.39
PT Millennium Pharmacon International Tbk · IDX:SDPCUS$13.47MUS$63.80M5.9×0.3×7.4×0.7×1.0%2.9×n/a
Genesis Fertility Center Public Company Limited · SET:GFCUS$12.70MUS$9.80M19.3×0.9×4.0×0.8×6.3%0.0×n/a
Talius Group Limited · ASX:TALUS$12.55MUS$9.78Mn/a1.9×n/a3.1×−19.1%0.1×n/a
Mukdahan International Hospital Public Company Limited · SET:HANNUS$12.20MUS$9.07M66.8×0.7×6.3×1.4×1.4%0.1×n/a
Alzai Health Corp. · TSXV:ALZIUS$11.86MUS$10.93Mn/a227×n/a11.2×n/a0.4×n/a
Unipharma Co., Ltd. · TPEX:6621US$11.79MUS$8.53Mn/a3.2×n/a2.0×−45.8%0.0×n/a
Eukedos SpA · MIL:EUKUS$11.73MUS$11.27Mn/a0.2×1.2×0.4×−1.4%0.0×n/a
ImExHS Ltd · ASX:IMEUS$11.16MUS$10.15Mn/a0.5×10.1×1.0×−10.0%0.0×n/a
Intrasense SA · EURONEXT:ALINSUS$11.00MUS$10.61Mn/a3.3×n/an/a−364.8%n/an/a
Median of the othersUS$12.03MUS$10.38M16.1×1.4×6.3×1.0×−1.4%0.0×-0.39

Forecasts

Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.

Price target
0.25 AUD · Analysts' mean
EPS, year to Jun 2027
-0.004 · 1 analyst
Revenue, year to Jun 2027
28.97M · 1 analyst

Team and board

Officers

OfficerRole
Gareth PyeChief Executive Officer
Neil ThompsonChief Financial Officer
Anna WinyardGeneral Manager, UK and Europe
Cheryl McCullaghGeneral Manager, ANZ Chief Clinical and Innovation Officer
David CrockettChief Growth Officer
Evan SimmonsHead of Diagnostics Products
Hani ObeidGeneral Manager, Saudi Arabia and Middle East
Julia CooperGeneral Manager of Health Roundtable
Kateena MillsHead of People & Culture
Larissa MasonHead of Clinical Decision Support
Marek StepniakHead of International
Stephen BadhamHead of Coding Products
Stephen MorganChief Technology Officer

Board

DirectorRole
Andy HardyNon-Executive Director
Emma Gray
Martin Bowles AO PSM
Mike HillNon-Executive Director
Stuart MacDonald

Events

QuarterResultsShare move
Q4 2025Aug 27, 2025−9.3%
Q2 2025Feb 18, 2025−16.1%
Q2 2023Feb 15, 2023 · Before open+12.3%
Q4 2022Aug 23, 2022 · After close+7.3%
Q2 2022Feb 14, 2022 · After close−7.3%
Q4 2021Aug 27, 20210.0%
Q2 2021Feb 22, 2021−4.0%

Open Events

Decks

DeckKindSlidesDate
FY2026 Earnings PresentationEarnings19 slidesAug 28, 2026
H1 2026 Earnings PresentationEarnings17 slidesFeb 19, 2026
FY2025 Earnings PresentationEarnings22 slidesAug 28, 2025
H1 2025 Earnings PresentationEarnings25 slidesFeb 19, 2025
Shareholder Meeting (November 2024)Shareholder meeting44 slidesNov 28, 2024
FY2024 Earnings PresentationEarnings30 slidesAug 27, 2024
FY2024 Earnings PresentationEarnings25 slidesAug 6, 2024
Investor Presentation (February 2024)Investor deck32 slidesFeb 14, 2024
Shareholder Meeting (November 2023)Shareholder meeting28 slidesNov 21, 2023
Investor Presentation (August 2023)Investor deck29 slidesAug 24, 2023
All 23 decks
DeckKindSlidesDate
Q3 FY23 Earnings PresentationEarnings17 slidesApr 27, 2023
Investor Presentation (February 2023)Investor deck32 slidesFeb 15, 2023
Shareholder Meeting (November 2022)Shareholder meeting23 slidesNov 24, 2022
Investor Presentation (August 2022)Investor deck28 slidesAug 24, 2022
Corporate Update (May 2022)Corporate update11 slidesMay 17, 2022
H1 FY2022 Earnings PresentationEarnings26 slidesMarch 2022
H1 FY2022 Earnings PresentationEarnings30 slidesFeb 15, 2022
Shareholder Meeting (October 2021)Shareholder meeting22 slidesOct 28, 2021
Merger or Acquisition (August 2021)Merger or acquisition25 slidesAug 30, 2021
H1 FY2021 Earnings PresentationEarnings30 slidesAug 27, 2021
Investor Presentation (August 2021)Investor deck35 slidesAug 27, 2021
Pacific Knowledge Systems — Investor Presentation (August 2020)Investor deck29 slidesAug 28, 2020
IPO Roadshow (June 2019)IPO roadshow40 slidesJun 14, 2019

Open Decks

Financials

Annual, in AUD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue29.2M28.6M27.6M22.8M16.5M8.39M4.12M294.4K3.87M3.05M
Cost of revenue29.9M23.7M22.7M20.6M16.7M5.62M1.47M281.4K50.0K32.0K
Gross profit-738.0K28.6M4.89M2.14M-202.0K2.77M2.65M13.0K3.82M3.02M
Research and development2.96M2.31M1.68M796.0K507.0K139.6K11.0K
Selling, general and administrative23.8M21.8M1.25M18.1M13.8M5.00M1.56M475.9K1.39M1.83M
Operating income-4.99M-6.23M-609.0K-7.01M-8.65M-1.03M188.0K-540.8K2.04M837.0K
Depreciation and amortization5.13M5.52M5.44M4.89M3.62M1.50M509.1K31.0K50.0K32.0K
EBITDA139.0K-713.0K4.83M-2.12M-5.03M465.3K697.1K-509.8K2.09M869.0K
Interest expense239.0K169.0K57.0K56.0K25.0K14.3K5.75K200
Income before tax-18.2M-6.35M-5.83M-6.19M-5.97M-491.8K331.1K-842.7K2.18M1.36M
Income tax86.0K-191.0K-724.0K719.0K-1.52M-108.1K-51.8K89.7K609.0K-1.19M
Net income-18.3M-6.16M-5.11M-6.91M-4.45M-383.6K382.9K-932.4K1.57M2.54M
Earnings per share, basic-0.06-0.02-0.02-0.03-0.02-0.000.00-0.010.010.02

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents2.51M4.78M5.04M8.81M6.35M14.1M4.20M4.14M285.0K1.25M
Short-term investments1.17M1.26M732.0K648.0K353.0K231.9K109.8K15.0K15.0K
Receivables5.48M3.54M6.48M5.64M6.90M1.78M990.1K1.19M470.0K590.0K
Inventory1.26M-333.0K1352.7K331.9K-293.2K
Current assets7.99M9.61M11.5M14.4M13.3M17.4M5.55M5.33M755.0K1.84M
Property, plant and equipment1.16M1.38M520.0K965.0K1.44M124.5K68.4K91.0K113.0K
Goodwill21.4M30.9M30.9M30.9M30.9M18.6M22.1M12.7M12.7M
Total assets37.4M54.3M59.7M62.5M63.9M47.1M32.2M21.4M6.97M5.42M
Accounts payable596.0K1.17M763.0K1.51M736.0K238.9K425.3K119.6K128.0K182.0K
Current liabilities12.8M7.81M9.00M12.2M8.92M3.76M2.79M975.1K1.42M1.45M
Long-term debt2.31M537.0K537.0K537.0K
Total debt4.04M3.26M1.66M755.0K1.12M799.4K44.3K
Total liabilities14.0M12.4M12.5M15.3M15.3M4.96M3.01M1.19M1.42M1.45M
Shareholders' equity23.4M41.9M47.1M47.2M48.6M42.1M29.2M20.2M5.55M3.98M
Shares outstanding290.2M289.6M281.4M246.4M240.0M198.5M145.9M117.5M113.9M113.9M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations931.0K609.0K-492.0K768.0K-2.32M240.7K1.05M-1.02M1.99M922.0K
Capital spending-151.0K-2.45M-4.02M-2.65M-2.51M-2.88M-1.07M-119.3K-386.0K-75.0K
Free cash flow780.0K-1.84M-4.51M-1.88M-4.83M-2.64M-26.1K-1.14M1.61M847.0K
Cash from investing-3.89M-2.45M-4.02M-2.65M-5.16M-2.98M-849.5K-15.6M-2.96M-1.35M
Cash from financing694.0K1.58M749.0K4.34M-286.0K12.6M-128.5K20.7M3.00K-1.20M
Dividends paid-109.0K
Share buybacks995.0K4.70M240.0K-540.4K021.7M3.00K0
Change in cash-2.27M-262.0K-3.77M2.46M-7.77M9.91M68.6K3.85M-965.0K1.25M

Open Financials

Filings

FilingDateTypeFiled with
Annual Report to shareholdersOct 22, 2026Annual reportASX
Notice of Annual General Meeting/Proxy FormOct 22, 2026Meeting noticeASX
Notification of cessation of securities - BMTOct 20, 2026FinancingASX
Notification of cessation of securities - BMTOct 6, 2026FinancingASX
Change of Director's Interest Notice - M HillSep 3, 2026Ownership change noticeASX
Change of Director's Interest Notice - M BowlesAug 31, 2026Ownership change noticeASX
Cleansing NoticeAug 27, 2026FinancingASX
Application for quotation of securities - BMTAug 27, 2026FinancingASX
FY26 Annual Results Investor PresentationAug 27, 2026Other filingsASX
Appendix 4G and Corporate Governance StatementAug 27, 2026Other filingsASX
All 107 filings
FilingDateTypeFiled with
FY26 Full-Year Investor UpdateAug 27, 2026ResultsASX
Appendix 4E and FY26 Annual ReportAug 27, 2026Annual reportASX
Notification of cessation of securities - BMTAug 13, 2026Notification letterASX
Cleansing NoticeAug 10, 2026FinancingASX
Application for quotation of securities - BMTAug 10, 2026FinancingASX
Cleansing NoticeAug 3, 2026FinancingASX
Application for quotation of securities - BMTAug 3, 2026FinancingASX
Proposed issue of securities - BMTJul 31, 2026FinancingASX
Variation to CEO's Employment AgreementJul 31, 2026Management or board changeASX
Beamtree appoints Gareth Pye as Chief Executive OfficerJun 14, 2026Management or board changeASX
$2m Saudi contract win & Strategic Review Interim UpdateMay 4, 2026Operations updateASX
1H FY26 Results - Investor PresentationFeb 18, 2026ResultsASX
BMT FY26 Half-Year Investor UpdateFeb 18, 2026Interim reportASX
Appendix 4D and FY26 Interim ReportFeb 18, 2026Interim reportASX
Q1 FY26 Trading Update, Continued MomentumOct 14, 2025Quarterly reportASX
FY25 Results Investor PresentationAug 27, 2025ResultsASX
FY25 Results AnnouncementAug 27, 2025ResultsASX
Preliminary Final ReportAug 27, 2025Annual reportASX
Beamtree Signs $1m Singapore Coding Audit ContractAug 27, 2025Operations updateASX
Strategic Partnership with NHS ConfederationMay 30, 2025Acquisition or disposalASX
Q3 FY25 Trading UpdateMay 5, 2025Quarterly reportASX
Strategic contract wins for Autonomous coding- ClarificationMar 24, 2025Operations updateASX
Pause in TradingMar 23, 2025Trading halt or suspensionASX
Strategic contract wins for Autonomous codingMar 23, 2025Operations updateASX
$4m contract win to deliver PICQ for the Republic of IrelandMar 20, 2025Material contractASX
1H FY25 Results - Investor PresentationFeb 18, 2025Interim reportASX
1H FY25 Results and Trading UpdateFeb 18, 2025ResultsASX
Appendix 4D and FY25 Interim ReportFeb 18, 2025Interim reportASX
Beamtree appoints new CEOFeb 3, 2025Management or board changeASX
Q1 FY25 Trading UpdateNov 3, 2024Quarterly reportASX
Tim Kelsey to step down as Beamtree CEO in March 2025Oct 14, 2024Management or board changeASX
Major recurring revenue contract win in Saudi ArabiaSep 24, 2024Operations updateASX
FY24 Results Investor PresentationAug 26, 2024Other filingsASX
FY24 Results AnnouncementAug 26, 2024Other filingsASX
FY24 Unaudited Annual Results - Investor PresentationAug 5, 2024Other filingsASX
Unaudited FY24 results, strong cashflow & good FY25 outlookAug 5, 2024GuidanceASX
Beamtree wins AU$3.6m contract in Saudi ArabiaMay 27, 2024Other filingsASX
Q3 FY24 Trading UpdateApr 30, 2024Quarterly reportASX
1H FY24 Investor PresentationFeb 13, 2024ResultsASX
1H FY24 Results and Trading UpdateFeb 13, 2024ResultsASX
Appendix 4D and FY24 Interim ReportFeb 13, 2024Interim reportASX
Annual General Meeting Addresses and PresentationNov 20, 2023Meeting outcomeASX
Q1 FY24 Trading UpdateOct 26, 2023Quarterly reportASX
FY23 Results AnnouncementAug 23, 2023Other filingsASX
FY23 Investor PresentationAug 23, 2023Other filingsASX
Q4 FY23 Trading UpdateJul 26, 2023Other filingsASX
Beamtree secures first contract in CanadaJun 8, 2023Other filingsASX
Beamtree completes $5m capital raiseMay 29, 2023Other filingsASX
Trading HaltMay 25, 2023Trading halt or suspensionASX
Q3 FY23 Trading Update PresentationApr 27, 2023Other filingsASX
Q3 FY23 Trading UpdateApr 26, 2023Other filingsASX
Appendix 4D and FY23 Interim ReportFeb 14, 2023Interim reportASX
1H FY23 Investor PresentationFeb 14, 2023Other filingsASX
1H FY23 Trading HighlightsFeb 14, 2023Other filingsASX
BMT agrees revised contract terms Health Roundtable LimitedJan 30, 2023Other filingsASX
Clarification of contract with AbbottDec 16, 2022Other filingsASX
Beamtree agrees new global contract with AbbottDec 15, 2022Other filingsASX
Beamtree Trading UpdateOct 30, 2022Other filingsASX
Beamtree announces partnership in Kingdom of Saudi ArabiaOct 10, 2022Other filingsASX
FY22 Results AnnouncementAug 23, 2022Other filingsASX
FY22 Investor PresentationAug 23, 2022Other filingsASX
BMT Business Update PresentationMay 17, 2022Operations updateASX
BMT Business UpdateMay 17, 2022Operations updateASX
BMT signs USD$7M 5-year contract for RippleDown DiagnosticsMay 9, 2022Other filingsASX
Beamtree confirms key renewalMar 30, 2022Other filingsASX
BMT accelerates international growth - first NHS contractsMar 21, 2022Other filingsASX
Half year results investor presentationFeb 14, 2022Interim reportASX
Beamtree 1H FY22 business update and financialsFeb 14, 2022Operations updateASX
Appendix 4D and half year reportFeb 14, 2022Interim reportASX
BMT and CALHN partner to pioneer AI for safer patient careSep 30, 2021Other filingsASX
Beamtree acquisition presentationAug 30, 2021Acquisition or disposalASX
Proposed issue of securities - BMTAug 30, 2021FinancingASX
Beamtree to acquire Potential(x)Aug 30, 2021Acquisition or disposalASX
Investor Presentation Financial Year 2021Aug 26, 2021Other filingsASX
Record FY21 results delivers sustainable growthAug 26, 2021Other filingsASX
Successful renewal of key contracts and new contract winsJun 28, 2021Material contractASX
Appendix 4D and Interim ReportFeb 22, 2021Interim reportASX
PKS receives $12 million in firm commitments to drive growthFeb 22, 2021Other filingsASX
PKS executes $2.5m renewal agreement with PhilipsJan 27, 2021Other filingsASX
PKS agreement with ACT Pathology extendedDec 22, 2020Other filingsASX
Cleansing Notice and Potential Customer Contract RenewalDec 4, 2020FinancingASX
PKS signs USD$1.65m agreement for national health data auditNov 18, 2020Other filingsASX
PKS appoints internationally regarded CEOOct 5, 2020Other filingsASX
PKS signs additional renewal agreement with HealthscopeSep 17, 2020Other filingsASX
PKS Investor Presentation Financial Year 2020Aug 28, 2020Other filingsASX
PKS update for the financial year ending 30 June 2020Aug 28, 2020Other filingsASX
2020 Annual Report to shareholders and Appendix 4EAug 28, 2020Annual reportASX
PKS signs new agreement with SA PathologyJul 12, 2020Other filingsASX
PKS acquires Pavilion HealthApr 20, 2020Acquisition or disposalASX
PKS signs renewal agreement with Healthscope NZApr 17, 2020Other filingsASX
Clarification on Renewal of AgreementApr 17, 2020Other filingsASX
Half Yearly Report and AccountsFeb 28, 2020Interim reportASX
PKS executes Abbott License and Distribution AgreementNov 19, 2019Other filingsASX
PKS update for quarter ending 30 September 2019Oct 29, 2019Other filingsASX
FY19 Results CommentaryAug 30, 2019Other filingsASX
Appendix 4EAug 30, 2019ResultsASX
IPO PresentationJun 14, 2019Other filingsASX

Open Filings

Cap table

Built by 6ix from Beamtree Holdings Ltd’s releases

Common shares
295,342,591
Fully diluted
295,342,591

Fully diluted

LineShares
Common shares295,342,591

Share count over time

CountShares
Nov 22, 2026295,342,591

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Andy HardyNon-Executive Director · Since at least Nov 4, 2026
Anna WinyardGeneral Manager, UK and Europe · Since at least Nov 5, 2026
Cheryl McCullaghGeneral Manager, ANZ Chief Clinical and Innovation Officer · Since at least Nov 5, 2026
David CrockettChief Growth Officer · Since at least Nov 5, 2026
Emma GrayDirector · Since at least Nov 5, 2026
Evan SimmonsHead of Diagnostics Products · Since at least Nov 4, 2026
Gareth PyeChief Executive Officer · Since Jun 15, 2026
Hani ObeidGeneral Manager, Saudi Arabia and Middle East · Since at least Nov 5, 2026
Julia CooperGeneral Manager of Health Roundtable · Since at least Nov 5, 2026
Kateena MillsHead of People & Culture · Since at least Nov 5, 2026
All 18 people
PersonSeat
Larissa MasonHead of Clinical Decision Support · Since at least Nov 4, 2026
Marek StepniakHead of International · Since at least Nov 5, 2026
Martin Bowles AO PSMDirector · Since at least Nov 5, 2026
Mike HillNon-Executive Director · Since at least Nov 4, 2026
Neil ThompsonChief Financial Officer · Since at least Nov 5, 2026
Stephen BadhamHead of Coding Products · Since at least Nov 4, 2026
Stephen MorganChief Technology Officer · Since at least Nov 5, 2026
Stuart MacDonaldDirector · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Beamtree Holdings Ltd.